Recently, we demonstrated that disrupted galectin-3 expression in male mice leads to the development of nonalcoholic fatty liver disease (NAFLD) and hepatocellular carcinoma (HCC) with liver fibrosis [18, 19]. This evidence concerns the gene LGALS3 and hepatocellular carcinoma.